Literature DB >> 3652048

Breast fluid cholesterol and cholesterol epoxides: relationship to breast cancer risk factors and other characteristics.

L D Gruenke1, M R Wrensch, N L Petrakis, R Miike, V L Ernster, J C Craig.   

Abstract

We measured levels of cholesterol and its oxidation products, 5,6 alpha- and beta-epoxides and their common hydrolysis product cholestane triol, in breast fluids of women without breast disease, compared these levels to serum cholesterol levels, and explored associations of these breast fluid measurements with known breast cancer risk factors and other characteristics. Subjects were 105 women with no history of breast disease from whom breast fluid could be obtained by nipple aspiration. The four breast fluid measurements were significantly correlated with each other (P less than 0.0001) but none was correlated with serum cholesterol. In subsequent analyses restricted to breast fluid cholesterol and cholesterol beta-epoxide, cholesterol levels (but not beta-epoxide levels) increased with age and were higher in white than nonwhite women. Both measurements were low in women who were lactating, who were parous, or who had breast-fed. The lower levels among parous women persisted for at least 2 years postpartum or postlactation. Because breast fluid levels of cholesterol beta-epoxide are reduced for some time following a birth or cessation of lactation, the alveolar-ductal systems of parous women presumably have less cumulative exposure to this potentially carcinogenic substance. This biochemical mechanism may, in part, explain the observed reduction of breast cancer risk associated with parity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652048

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Dietary intake of lactose as a strong predictor for secretor status of nipple aspirate fluid in healthy premenopausal nonlactating women.

Authors:  Yafei Huang; Karl E Anderson; Manubai Nagamani; James J Grady; Lee-Jane W Lu
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

Review 2.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

3.  Cholesterol, lipoproteins, and breast cancer risk in African American women.

Authors:  Adana A Llanos; Kepher H Makambi; Cynthia A Tucker; Sherrie Flynt Wallington; Peter G Shields; Lucile L Adams-Campbell
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

Review 4.  Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review.

Authors:  M R Wrensch; N L Petrakis; L D Gruenke; V L Ernster; R Miike; E B King; W W Hauck
Journal:  Breast Cancer Res Treat       Date:  1990-01       Impact factor: 4.872

5.  Nutrients and nipple aspirate fluid composition: the breast microenvironment regulates protein expression and cancer aetiology.

Authors:  Ferdinando Mannello; Gaetana A Tonti; Franco Canestrari
Journal:  Genes Nutr       Date:  2008-06-27       Impact factor: 5.523

6.  Association of breast fluid coloration with age, ethnicity, and cigarette smoking.

Authors:  N L Petrakis; R Miike; E B King; L Lee; L Mason; B Chang-Lee
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

7.  The biochemistry of breast cyst fluids and duct secretions.

Authors:  O W Sartorius
Journal:  Breast Cancer Res Treat       Date:  1995-09       Impact factor: 4.872

8.  Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women.

Authors:  Jessica A Miller; Patricia A Thompson; Iman A Hakim; Ana Maria Lopez; Cynthia A Thomson; Chiu-Hsieh Hsu; H-H Sherry Chow
Journal:  Biomark Res       Date:  2013-04-15

Review 9.  Nipple Aspirate Fluid at a Glance.

Authors:  Susana I S Patuleia; Karijn P M Suijkerbuijk; Elsken van der Wall; Paul J van Diest; Cathy B Moelans
Journal:  Cancers (Basel)       Date:  2021-12-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.